- Female
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Updates
- Natural Killer Cell Therapeutics Market Analysis and Forecast, 2022-2032
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032
The growth in the global NK cell therapeutics market is expected to be driven by the rising in the number of clinical trials and the increasing incidence and prevalence of cancer cases.
https://bisresearch.com/industry-report/natural-killer-cell-therapeutics-market.htmlNatural Killer Cell Therapeutics Market Analysis and Forecast, 2022-2032 The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032 The growth in the global NK cell therapeutics market is expected to be driven by the rising in the number of clinical trials and the increasing incidence and prevalence of cancer cases. https://bisresearch.com/industry-report/natural-killer-cell-therapeutics-market.html0 0 21152
- Big Data in Healthcare Market Analysis and Forecast 2031
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is expected to reach $130,132.1 million by the end of 2031. The market is expected to grow at a CAGR of 13.96% during the forecast period 2022-2031.
https://bisresearch.com/industry-report/global-big-data-healthcare-market.htmlBig Data in Healthcare Market Analysis and Forecast 2031 The global big data in healthcare market was valued at $32,925.1 million in 2021 and is expected to reach $130,132.1 million by the end of 2031. The market is expected to grow at a CAGR of 13.96% during the forecast period 2022-2031. https://bisresearch.com/industry-report/global-big-data-healthcare-market.html0 0 5207 - ENT Devices Market
The global ENT devices market report highlights that the market was valued at $13,799.5 million in 2020 and is expected to reach $25,127.7 million by the end of 2030.
https://bisresearch.com/industry-report/ent-devices-market.htmlENT Devices Market The global ENT devices market report highlights that the market was valued at $13,799.5 million in 2020 and is expected to reach $25,127.7 million by the end of 2030. https://bisresearch.com/industry-report/ent-devices-market.html0 0 1320 - FLT3 Inhibitors Market Analysis and Forecast, 2022-2032
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global FLT3 inhibitors market growth is expected to be driven by the introduction of novel products, the increasing incidence of acute myeloid leukemia, and the rising research and development investments, among others.
https://bisresearch.com/industry-report/flt3-inhibitors-market.htmlFLT3 Inhibitors Market Analysis and Forecast, 2022-2032 The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the introduction of novel products, the increasing incidence of acute myeloid leukemia, and the rising research and development investments, among others. https://bisresearch.com/industry-report/flt3-inhibitors-market.html0 0 25031 - Digital Biomanufacturing Market Analysis and Forecast, 2022-2031
The global digital biomanufacturing market is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.
https://bisresearch.com/industry-report/digital-biomanufacturing-market.htmlDigital Biomanufacturing Market Analysis and Forecast, 2022-2031 The global digital biomanufacturing market is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031. https://bisresearch.com/industry-report/digital-biomanufacturing-market.html0 0 15231 - Axial Spondyloarthritis Market Analysis and Forecast, 2022-2032
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.
https://bisresearch.com/industry-report/axial-spondyloarthritis-market.htmlAxial Spondyloarthritis Market Analysis and Forecast, 2022-2032 The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032. https://bisresearch.com/industry-report/axial-spondyloarthritis-market.html0 0 16222 - MRD Testing Market - A Global and Country Analysis 2022- 2027
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
https://bisresearch.com/industry-report/mrd-testing-market.htmlMRD Testing Market - A Global and Country Analysis 2022- 2027 The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%. https://bisresearch.com/industry-report/mrd-testing-market.html0 0 16114 - Liquid Biopsy Market Analysis and Forecast, 2022-2032
The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032.
https://bisresearch.com/industry-report/liquid-biopsy-market-report.htmlLiquid Biopsy Market Analysis and Forecast, 2022-2032 The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032. https://bisresearch.com/industry-report/liquid-biopsy-market-report.html0 0 17894
Load More